lifitegrast (Xiidra)
Jump to navigation
Jump to search
Indications
Dosage
- 1 drop OU BID (~ q12 hours)
- Xiidr (lifitegrast ophthalmic solution) 5%
Adverse effects
- eye irritation, discomfort or blurred vision
- dysgeusia
Mechanism of action
More general terms
Additional terms
References
- ↑ FDA News Release. July 12, 2016 FDA approves new medication for dry eye disease http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm510720.htm
- ↑ Xiidr Prescribing Information http://www.shirecontent.com/PI/PDFS/XIIDRA_USA_ENG.pdf